Differential Expression of a Cutaneous Corticotropin-Releasing Hormone System

Endocrinology

Volumn 145, Issue 2, 2004, Pages 941-950

  Slominski, Andrzej ^a,e   Pisarchik, Alexander ^a   Tobin, Desmond J ^b   Mazurkiewicz, Joseph E ^c   Wortsman, Jacobo ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c ALBANY MEDICAL COLLEGE   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Department of Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1ALPHA; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2 ANTIGEN; CORTICOTROPIN RELEASING HORMONE BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN II;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER CELL; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; DERMIS; EPIDERMIS; FIBROBLAST; GENE EXPRESSION; GENE LOCATION; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MELANOCYTE; MELANOMA CELL; MOUSE; MUSCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEBACEOUS GLAND; SIGNAL TRANSDUCTION; SKIN; SKIN CELL; SKIN FUNCTION; SPECIES COMPARISON; SUBCUTANEOUS FAT; SUBCUTANEOUS TISSUE; SWEAT GLAND;

ALTERNATIVE SPLICING; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; DERMIS; EPIDERMIS; FEMALE; FIBROBLASTS; GENE EXPRESSION; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MELANOCYTES; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCALP; SIGNAL TRANSDUCTION; SKIN; SPECIES SPECIFICITY;

EID: 0842291543     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0851     Document Type: Article

References (51)

1. Aguilera G 1998 Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab 9:329-336
2. Dautzenberg FM, Hauger RL 2002 The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23:71-77
3. Grammatopoulos DK, Chrousos GP 2002 Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13:436-444
4. Perrin MH, Vale WW 1999 Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885:312-328
5. Linton EA, Woodman JR, Asboth G, Glynn BP, Plested CP, Bernal AL 2001 Corticotrophin releasing hormone: its potential for a role in human myometrium. Exp Physiol 86:273-281
6. Slominski A, Wortsman J, Luger T, Paus R, Salomon S 2000 Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020
7. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET 2001 Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15:1678-1693
8. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB 1996 Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17:166-172
9. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE 2001 Urocortin II: a member of the corticotropin-releasing factor (CRF)neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98: 2843-2848
10. Hsu SY, Hsueh AJW 2001 Human stresscopin and stresscopin-related peptide are selective ligands for the corticotropin-releasing hormone receptor. Nat Med 7:605-611
11. Seasholtz AF, Valverde RA, Denver RJ 2002 Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J Endocrinol 175:89-97
12. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW 1991 Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349:423-426
13. Sakai K, Yamada M, Horiba N, Wakui M, Demura H, Suda T 1998 The genomic organization of the human corticotropin-releasing factor type-1 receptor. Gene 219:125-130
14. Grammatopoulos DK, Dai Y, Randeva HS, Levine M, Karteris E, Eastern A, Hillhouse EW 1999 A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol 13:2189-2202
15. Pisarchik A, Slominski A 2001 Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15:2754-2756
16. Catalano RD, Kyriakou T, Chen J, Easton A, Hillhouse EW 2003 Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol Endocrinol 17:395-410
17. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grogoriadis EE, DeSouza EB 1996 Cloning and characterization of he human corticotropin-releasing factor-2 receptor complementary deoxyrubonucleic acid. Endocrinology 137: 72-77
18. 2g receptor. Mol Endocrinol 12:1077-1085
19. Valdenaire O, GIller T, Breu V, Gottowick J, Kilpatrick G 1997 A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim Biophys Acta 1352:129-132
20. Kono M, Nagata H, Umemura S, Kawana S, Osamura RY 2001 In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 15:2759-2766
21. Quevedo MA, Slominski A, Pinto W, Wei E, Wortsman J 2001 Pleiotropic effects of corticotropin releasing hormone (CRH) on normal human keratinocytes. In Vitro Cell Dev Biol 37:50-54
22. Slominski A, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E 1999 Cutaneous expression of CRH and CRH-R: is there a "skin stress system?" Ann NY Acad Sci 885:287-311
23. Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J 1998 Characterization of corticotropin releasing hormone (CRH) in human skin. J Clin Endocrinol Metab 83:1020-1024
24. Slominski A, Roloff B, Curry J, Dahiya M, Szczesniewski A, Wortsman J 2000 The skin produces urocortin. J Clin Endocrinol Metab 85:815-823
25. Slominski A, Szczesniewski A, Wortsman J 2000 Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab 85:3582-3588
26. Pisarchik A, Slominski A 2002 Corticotropin releasing hormone receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin. J Invest Derm 118:1065-1072
27. Slominski A, Paus R, Plonka P, Maurer M, Chakraborty A, Pruski D, Lukiewicz S 1994 Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol 102:862-869
28. Kauser S, Schallreuter KU, Thody AJ, Gummer C, Tobin DJ 2003 Regulation of human epidermal melanocye biology by β-endorphin. J Invest Dermatol 120:1073-1080
29. Tobin DJ, Bystryn J-C 1996 Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res 916:304-310
30. Slominski A 1988 Identification of β-endorphin, α-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells. Exp Dermatol 7:213-216
31. Slominski A, Ermak G, Wortsman J 1999 Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol 35:564-565
32. Coburn SP, Slominski A, Mahuren JD, Wortsman J, Hessle L, Millan JL 2003 Cutaneous metabolism of vitamin B-6. J Invest Dermatol 120:292-300
33. Slominski A, Moellman G, Kuklinska E, Bomirski A, Pawelek J 1988 Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway: L-tyrosine and L-dopa. J Cell Sci 89:287-296
34. Slominski A, Moellmann G, Kuklinska E 1989 MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cAMP levels and tyrosinase activity without inducing melanogenesis. J Cell Sci 92:551-559
35. Bomirski A, Wrzolkowa T, Arendarczyk M, Bomirska M, Kuklinska E, Slominski A, Moellmann G 1987 Pathology and ultrastructural characteristics of a hypomelanotic variant of transplantable hamster melanoma with high tyrosinase actiity. J Invest Derm 89:469-473
36. Castro MG, Morrison E, Perone MJ, Brown OA, Murray CA, Ahmed I, Perkins AV, Europe-Firmer G, Lowenstein PR, Linton EA 1996 Corticotrophin-releasing hormone receptor type 1: generation and characterization of polyclonal antipeptide antibodies and their localization in pituitary cells and cortical neurones in vitro. J Neuroendocrinol 8:521-531
37. Rodriguez-Linares B, Linton EA, Phaneuf S 1998 Expression of corticotrophin-releasing hormone receptor mRNA and protein in the human myometrium. J Endocrinol 156:15-21
38. Lei S, Richter R, Bienert M, Mulvany MJ 1993 Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 108:941-947
39. Dashwood MR, Andrews HE, Wei ET 1987 Binding of [125I]Tyr-corticotropin- releasing factor to rabbit aorta is reduced by removal of the endothelium. Eur J Pharmacol 135:111-112
40. Barker DM, Corder R 1999 Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine. Br J Pharmacol 126:317-325
41. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR 2002 Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 99:7148-7153
42. 42: Preil J, Muller MB, Gesing A, Reul JM, Sillaber I, van Gaalen MM, Landgrebe J, Holsboer F, Stenzel-Poore M, Wurst W 2001 Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 142:4946-4955
43. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF 1998 Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102
44. Rivier CL, Grigoriadis DE, Rivier JE 2003 Role of corticotropin- releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology 144:2396-2403
45. Slominski A, Ermak, Hwang J, Mazurkiewicz J, Corliss, Eastman A 1996 The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta 1289: 247-251
46. Roloff B, Fechner K, Slominski A, Furkert J, Botchkarev VA, Bulfone-Paus S, Zipper J, Krause E, Paus R 1998 Hair cycle-dependent expression of corticotropin releasing factor (CRF) and CRF receptors (CRF-R) in murine skin. FASEB J 12:287-297
47. Slominski A, Ermak G, Hwang J, Chakraborty A, Mazurkiewicz JE, Mihm M 1995 Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 374:113-116
48. LePoole C, Boissy R, Sarangarajan R, Chen J, Forristal J, Sheth P, Westerhof W, Babcock G, Das P, Saelinger C 2000 PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol 36:309-319
49. Slominski A, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J, Wortsman J 2000 Corticotropin releasing hormone (CRH) and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol 36:211-216
50. Pawelek JM 1976 Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol 66:201-209
51. Bennett DC 1991 Colour genes, oncogenes and melanocyte differentiation. J Cell Sci 98:135-139